Showing results (341-350 of 808) with videos related to
Sort By:
Pageof 81
Cell Death Discovery|July 28, 2023
Disruption of RCAN1.4 expression mediated by YY1/HDAC2 modulates chronic renal allograft interstitial fibrosisJianjian Zhang, Yao Zhang, Dengyuan Feng, et al.Huan Jing Ke Xue= Huanjing Kexue|December 15, 2011
[Distribution, source and risk assessment of polycyclic aromatic hydrocarbons in river sediment of Cheng-Yu economic zone]Zhi Tang, Hai-Qing Liao, Liang Zhang, et al.Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|September 2, 2004
[Influence of cervical curvature change on the nerve root and vertebral artery of patients with cervical spondylosis and clinical observation of manipulation treatment]Gui-Kang Wei, Jian Wei, Hong-Hai Zhou, et al.Journal of Asian Natural Products Research|February 26, 2010
Schisanlactone H and sphenanthin A, new metabolites from Schisandra sphenantheraSan-Yun Zhou, Wei-Guang Wang, Hong-Mei Li, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 29, 2026
IL-17/Th17-Treg Axis regulation by Huangqi Gancao decoction in immunosuppression: Integrating network pharmacology, metabolomics, and in vivo validationKe Zhou, Hai Zhou, Ting Ma, et al.BMC Anesthesiology|August 19, 2024
Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trialQinyu Jiang, Yu Qi, Meiyan Zhou, et al.DNA and Cell Biology|June 20, 2020
Identification of <i>PIGU</i> as the Hub Gene Associated with KRAS Mutation in Colorectal Cancer by Coexpression AnalysisMeng Zhang, Hai-Zhou Wang, Hai-Ou Li, et al.British Journal of Haematology|May 16, 2021
Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopeniaYafei Yu, Yu Hou, Yajing Zhao, et al.International Journal of Molecular Sciences|December 10, 2021
Initiation and Execution of Programmed Cell Death and Regulation of Reactive Oxygen Species in PlantsChanjuan Ye, Shaoyan Zheng, Dagang Jiang, et al.Technology in Cancer Research & Treatment|September 23, 2022
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired <i>MET</i> AmplificationDantong Sun, Junyan Tao, Weihua Yan, et al.Pageof 81